Dhara B. WaghelaAssociateSheppard, Mullin, Richter & Hampton LLPWebsitewww.sheppardmullin.comConnectEmail424-288-5331 Professional Biography Dhara Waghela is an associate in the Corporate Practice Group in the firm's Century City office and is a member of the firm’s Healthcare team. More Legal and Business Bylines From Dhara B. Waghela Do Your Medical Director Arrangements Meet the Top Five Best Practices? - (Posted On Thursday, June 15, 2023) PE Firms Face Liability for the Conduct of their Portfolio Companies: Are you Paying Attention? - (Posted On Monday, April 03, 2023) Putting the Brakes on Healthcare M&A and Provider/Payor Contracting: AB 2080 Poised to Dramatically Impact Healthcare Transactions in California - (Posted On Thursday, July 07, 2022) HIPAA and COVID-19 Vaccination Status: The Office of Civil Rights Issues Workplace Guidance - (Posted On Wednesday, October 13, 2021) Executive Order on Promoting Competition in the American Economy: The Biden Administration Considers Drug Pricing Strategies While Keeping the “Most Favored Nations” Drug Reimbursement Program on the Sidelines - (Posted On Friday, August 20, 2021) The American Rescue Plan Act of 2021: A New Lease on Life for the Affordable Care Act? - (Posted On Friday, March 26, 2021) Medicare Part B Most Favored Nation Drug Pricing Model: New Rules, New Lawsuits, New Tweets - (Posted On Monday, December 21, 2020) ERISA: The Erosion of State Health Regulation Rights - (Posted On Wednesday, November 04, 2020) The Death of RBG…and the ACA? - (Posted On Friday, September 25, 2020) The Next in the Series of Executive Orders Affecting the Pharmaceutical Industry - (Posted On Friday, September 18, 2020) Pagination Page 1 Next page Next › Current Legal Analysis Breaking Down Federal Policies to Address Drug Shortages by: McDermott + Consulting PPPlease Stop Fraud: Two Whistleblowers Awarded $2.5 Million in PPP Fraud Settlement by: Tycko & Zavareei Whistleblower Practice Group On July 1, 2024, Texas May Have the Strongest Consumer Data Privacy Law in the United States by: Elizabeth Rogers 10 Creative Ways for Lawyers to Repurpose Content by: Stefanie M. Marrone FDA Gets Technical on HCT/P Rules in Warning Letter to Human Tissue Company by: Dominick DiSabatino , Cortney Inman Upcoming Legal Education Events Jun 26 2024 TSCA Reform — Eight Years Later Jun 18 2024 There Is More to TSCA Reporting Than CDR: TSCA Sections 8(a), (c), (d), and (e) Jun 12 2024 Preparing for HHS’s 340B Administrative Dispute Resolution (“ADR”) Reboot – Lessons from the Field Jun 12 2024 Sponsor’s Role in Regulatory Testing — Complying with GLP Standards Print